Company: EDSA
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001171843-25-002028
Chunk: 39

Company: Edesa Biotech, Inc.
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 39
---
 |     |                      |  54,075 |   |     |      |   13,547 |   |     |                      |   12,024 |   |
| Change in fair value of equity awards granted in prior years that vested during the year                     |     |      |   12,602 |   |     |                      |   4,102 |     |      |    7,808 |   |     |                      |   4,573 |   |     |      | (188,611 | ) |     |                      | (196,240 | ) |
| Compensation Actually Paid Totals                                                                            |     | $    |  488,181 |   |     | $                    | 407,151 |     | $    |  531,086 |   |     | $                    | 354,350 |   |     | $    |  (93,190 | ) |     | $                    |  (66,161 | ) |

23

| * | For 2024, includes the fair value of restricted share units issued to Dr. Nijhawan (PEO) as partial payment of salary, which is reflected in the “Salary” column of the Summary Compensation Table for such year.                                                                   
 For 2023, includes the fair value of restricted share units issued to Dr. Nijhawan (PEO), Mr. Brooks (Non-PEO) and Ms. Niffenegger (Non-PEO) as partial payment of each of their bonuses, which is reflected in the "Bonus" column of the Summary Compensation Table for such year. |

| (3) | The dollar amounts reported represent the average of the amounts reported for our company’s Non-PEO NEOs as a group (excluding Dr. Nijhawan) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the named executive officers (excluding Dr. Nijhawan) included for purposes of calculating the average amounts in each applicable year are as follows: for 2023, Mr. Lemieux and Dr. Brooks, for 2023, Mr. Lemieux, Dr. Brooks and Ms. Niffenegger and for 2022, Dr. Brooks and Ms. Niffenegger. Mr. Lemieux was appointed Chief Financial Officer effective July 15, 2023. |
| (4) | Cumulative TSR is calculated by dividing the sum of the cumulative